Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms
Clinical and Translational Oncology · 2024
DOI: 10.1007/s12094-024-03797-7 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Translational Oncology, 2024. Verfasst von Yuxia Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Affiliated Hospital of Guangdong Medical University, Renmin Rd, Xiashan District, Zhanjiang, Guangdong, 524000, Peo…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Autophagy, Bile Duct Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: This work was supported by the Guangdong Basic and Applied Basic Research Foundation, High-level Hospital Construction Project of Guangdong Provincial People's Hospital, Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province.
Abstract (Originalsprache)
The role of autophagy in cholangiocarcinogenesis and its development is intricate. Autophagy has a dual role in cholangiocarcinoma, and understanding the function and mechanism of autophagy in cholangiocarcinoma is pivotal in guiding therapeutic approaches to its treatment in clinical settings. Recent studies have revealed that autophagy is involved in the complex biological behavior of cholangiocarcinoma. In this review, we have summarized the genes and drugs that would promote or inhibit autophagy, leading to change in cellular behaviors of cholangiocarcinoma, including apoptosis, proliferation, invasion and migration, and influence its cellular drug resistance. In addition, we concluded the signaling pathways modulating autophagy in cholangiocarcinoma cells, including PI3K/AKT/mTOR,p38MAPK,AMPK/mTOR,LKB1-AMPK, and AKT/WNK1, and ERK signaling pathways, which subsequently impacting apoptosis, death, migration, invasion, and proliferation. In conclusion, we would like that we can provide ideas for future cholangiocarcinoma treatment by comprehensively summarizing the latest studies on the relationship between autophagy and cholangiocarcinoma, including the factors affecting autophagy and related signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Laboratory, Affiliated Hospital of Guangdong Medical University, Renmin Rd, Xiashan District, Zhanjiang, Guangdong, 524000, People's Republic of China.
- Institute of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang, 524023, Guangdong, People's Republic of China.
- Department of Medical Laboratory, Affiliated Hospital of Guangdong Medical University, Renmin Rd, Xiashan District, Zhanjiang, Guangdong, 524000, People's Republic of China. zengt@smu.edu.cn.
Förderung
- This work was supported by the Guangdong Basic and Applied Basic Research Foundation
- High-level Hospital Construction Project of Guangdong Provincial People's Hospital
- Special Fund Project for Science and Technology Innovation Strategy of Guangdong Province
- Natural Science Foundation of Xinjiang Uygur Autonomous Region
Zitieren
APA
Yang, Y., Li, Q., Chu, L. T., Lin, X., Chen, H., Chen, L., Tang, J., & Zeng, T. (2024). Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-024-03797-7
Vancouver
Yang Y, Li Q, Chu LT, Lin X, Chen H, Chen L, et al. Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms. Clinical and Translational Oncology. 2024. doi:10.1007/s12094-024-03797-7
BibTeX
@article{Yang2024,
author = {Yang, Yuxia and Li, Qiuyan and Chu, Lok Ting and Lin, Xiaocong and Chen, Helian and Chen, Linsong and Tang, Jinjing and Zeng, Tao},
title = {Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms},
journal = {Clinical and Translational Oncology},
year = {2024},
doi = {10.1007/s12094-024-03797-7}
}
EUVIMED